Maxay Muhiim u tahay Baaritaanka Multiplex Xilligan Neefsashada?

Toddobaadkan, Bandhigga Daawada Shaybaarka Caalamiga ah ee Guangzhou iyo In Vitro Diagnostics ayaa dhacaya 2026, baaritaanka cudur-sidaha neefsashada ee multiplex waa mid ka mid ah mowduucyada ugu dhow ee goobta laga daawado. Dareenkan waxaa ka dambeeya isbeddel dhab ah oo ku yimid dhaqanka caafimaadka: muuqaalka cudur-sidaha ee caabuqyada neefsashada ayaa ka wareegay su'aal "hal-doorasho" una wareegtay mid "doorasho badan".

Xogta ugu dambeysay ee la socodka ee Xarunta Xakamaynta iyo Kahortagga Cudurrada ee Shiinaha (CDC) waxay muujineysaa in Toddobaadkii 43aad ee 2026, oo ka mid ah muunadaha neefsashada ee laga helay kiisaska cudurka hargabka u eg (ILI) ee bukaan-socodka isbitaalka iyo waaxaha gurmadka degdegga ah, heerarka togan waxay ahaayeen 14.7%fayraska hargabka, 11.7% fayraska rhinovirus, 4.1% fayraska metapneumovirus ee aadanaha, 4.3% fayraska parainfluenza, iyo 4.2%enterovirus. Fayraska neefsashada ee isku-dhafans, fayraska 'adenovirus', fayraska bocavirus, iyo Mycoplasma pneumoniaeWaxaa sidoo kale la ogaaday. Kiisaska isbitaallada la dhigay ee caabuqa neef-mareenka ee daran (SARI), heerka togan ee fayraska rhinovirus wuxuu gaaray 11.0% wuxuuna sii waday inuu kordho marka la barbar dhigo usbuucii hore. Falanqayn hore oo ay sameeyeen Guddiga Caafimaadka Qaranka ayaa sidoo kale si cad u sheegtay in sii kordhaya cudurrada neef-mareenka ee degdegga ah ay la xiriirtay isku-gudbinta iyo isku-darka jeermisyada neefsashada ee badan. Dhakhaatiirta ku jira goobaha bukaan-socodka iyo kuwa gurmadka degdegga ah hadda ma weydiinayaan oo keliya "Ma hargab baa?" laakiin "Waa maxay cudur-sidaha - ama dhowr ka mid ah ayaa isku mar jira?"

Isbeddelkan waxaa si toos ah uga muuqda istiraatiijiyadaha tijaabada. Heshiiska Khabiirka ee 2026 ee ku saabsan Codsiga Caafimaad ee Macquulka ah ee Baaritaanka Cudurrada Badan ee Cudurrada Faafa wuxuu dejiyaa mabaadi'da asaasiga ah ee baaritaanka "heer sare iyo mid shaqsiyeed" wuxuuna ka soo horjeedaa baaritaanka guddi ballaaran oo aan kala sooc lahayn oo aan kala sooc lahayn iyada oo aan la tilmaamin. Goobaha bukaan-socodka iyo xaaladaha degdegga ah, is-afgaradku wuxuu bixiyaa waddo cad: kiisaska khafiifka ah ee loo baahan yahay aqoonsiga cudurka, baaritaanka antigen-ka degdega ah ama baaritaanka aashitada nucleic-ka ee 2-6-bartilmaameed waa in la door bidaa, iyadoo la raacayo waqti soo celin ah (TAT) oo ah 2 saacadood gudahood; dhallaanka iyo carruurta yaryar, dadka waaweyn, ama bukaanada aan ka jawaabin daaweynta tijaabada ah, baaritaanka waxaa loo ballaarin karaa 2-10 bartilmaameed si loo taageero daaweynta ka hortagga faafa ee la beegsaday. Goobaha bukaan-jiifka iyo kuwa daran, baaritaanka waxaa loo sii kordhinayaa baaritaanka aashitada nucleic-ka ee 10-20-bartilmaameed ah, oo daboolaya jeermiska caadiga ah iyo hiddo-sideyaasha iska caabbinta antimicrobial-ka. Si kale haddii loo dhigo, waxa ay dhakhaatiirtu u baahan yihiin maaha "baaritaanno badan, ayaa ka wanaagsan," laakiin natiijooyin la fasiran karo ayaa lagu keenayaa goobta saxda ah, iyadoo la isku darayo bartilmaameedka saxda ah, daaqad waqti la aqbali karo.

Soo-saareyaasha reagent-ka IVD, saameynta wadadan caafimaad waa cad: qiimaha badeecadu kuma jirto ururin fudud oo lambarrada bartilmaameedka ah, laakiin waxay ku jirtaa inay buuxin karto shuruudaha adag ee goobaha bukaan-socodka iyo xaaladaha degdegga ah ee loogu talagalay TAT iyo caymiska bartilmaameedka, iyo inay gaari karto hawlgal "muunad-gelin, natiijo-bixin" oo heer sare ah oo ku yaal goobaha daryeelka aasaasiga ah. Maadaama dhaqdhaqaaqa isku mar ah ee in ka badan toban cudur-sidaha uu noqdo mid caadi ah xilliga dayrta iyo jiilaalka, baaritaanka multiplex wuxuu ka wareegayaa "dheeraad ikhtiyaari ah" una wareegayaa kaabayaasha muhiimka ah ee ogaanshaha kala duwanaanshaha etiological ee goobaha bukaan-socodka iyo xaaladaha degdegga ah.